✦ LIBER ✦
Brentuximab vedotin, a highly active ADC as a new therapeutic option for CD30+ lymphomas
✍ Scribed by Stamatopoulou, Sofia
- Book ID
- 121585922
- Publisher
- Springer-Verlag
- Year
- 2013
- Tongue
- English
- Weight
- 649 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1865-5041
No coin nor oath required. For personal study only.